Company intelligence / Profile preview

IMEDIPLUS

Zhubei City, Hsinchu County, Taiwan

Ownership: Private
Employees: ~31
Development stage: Other

Overview

IMEDIPLUS is a Taiwan-based healthcare technology and medical device company focused on digital auscultation, cardiac monitoring, and connected medical electronics. The company is best known for developing electronic and digital stethoscopes and related cloud- and AI-enabled systems intended to support diagnosis, screening, and remote monitoring. Its products and branding appear under names including IMEDIPLUS, iMEDI+, CaRDIaRT, and Cardicloud. Publicly available information indicates a commercial-stage business centered on medical hardware integrated with digital health software rather than a therapeutic drug pipeline. The company has also been described as serving cardiac care and broader medical monitoring needs.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware
Industry: Physiological Monitoring

Beyond the preview

Go deeper on IMEDIPLUS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMEDIPLUS.

Explore the full profile